Your browser doesn't support javascript.
loading
Research advances in the treatment of liver failure with mesenchymal stem cell-derived exosomes / 中华肝脏病杂志
Chinese Journal of Hepatology ; (12): 249-252, 2022.
Article in Zh | WPRIM | ID: wpr-935936
Responsible library: WPRO
ABSTRACT
Liver failure is a serious clinical syndrome in which multiple pathogenic factors exceed the liver's self-repair capability, resulting massive hepatocellular necrosis, rapid disease progression and high mortality. Liver transplantation is the most effective method for the treatment of liver failure, but it has disadvantages, such as insufficient liver donor and high cost. The clinical efficacy of mesenchymal stem cells in liver failure have been validated, but its application has been limited to certain extent. Cell-free-based therapies, especially mesenchymal stem cell-derived exosomes, has become a research hotspot in recent years. This paper reviews the research advances in the treatment of liver failure with the use of mesenchymal stem cell-derived exosomes.
Subject(s)
Full text: 1 Index: WPRIM Main subject: Liver Failure, Acute / Liver Failure / Hepatic Insufficiency / Exosomes / Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy Limits: Humans Language: Zh Journal: Chinese Journal of Hepatology Year: 2022 Type: Article
Full text: 1 Index: WPRIM Main subject: Liver Failure, Acute / Liver Failure / Hepatic Insufficiency / Exosomes / Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy Limits: Humans Language: Zh Journal: Chinese Journal of Hepatology Year: 2022 Type: Article